Diclofenac and Meloxicam Exhibited Anti-Virulence Activities Targeting Staphyloxanthin Production in Methicillin-Resistant .

() is a worldwide leading versatile pathogen that causes a wide range of serious infections. The emergence of antimicrobial resistance against resulted in an urgent need to develop new antimicrobials in the new era. The methicillin-resistant (MRSA) prevalence in hospital and community settings necessitates the discovery of novel anti-pathogenic agents.

Staphyloxanthin as a Potential Novel Target for Deciphering Promising Anti- Agents.

is a fatal Gram-positive pathogen threatening numerous cases of hospital-admitted patients worldwide. The emerging resistance of the pathogen to several antimicrobial agents has pressurized research to propose new strategies for combating antimicrobial resistance. Novel strategies include targeting the virulence factors of .